The V3 loop of the human immunodeficiency virus (HIV) surface protein, gpl20, constitutes a principal neutralizing determinant. HIV strains lacking a naturally conserved N-linked oligosaccharide (at position 306) within the V3 loop are highly sensitive to neutralization. We subjected molecular clones of HIVLA ~ lacking this 3°6N-glycan to in vitro immune selection with MAbs directed against the V3 loop. In all, ten clones were characterized, and all proved resistant to V3-directed neutralization. Sequencing of the V3 loop revealed that six of the clones had become resistant at least partly by reacquisition of the 3°6N-glycan. Only two of the clones possessed mutations within the binding site of the antibody itself, while the two remaining c...
The monoclonal antibody (MAb) 2G12 recognizes a cluster of high-mannose oligosaccharides on the huma...
AbstractThe N-glycan g15 within the HIV-1 gp120 V3 loop efficiently blocks antibodies to facilitate ...
The N-linked oligomannose glycans of HIV gp120 are a target for both microbicide and vaccine design....
The V3 region of the human immunodeficiency virus type 1 envelope protein gp120 constitutes a potent...
AbstractA conserved N-glycan present within the V3 loop of gp120 modulates the sensitivity to neutra...
AbstractA conserved N-glycan present within the V3 loop of gp120 modulates the sensitivity to neutra...
The HIV-1 surface glycoprotein, gp120, is made of a rapidly mutating protein core and an extensive c...
The HIV-1 surface glycoprotein, gp120, is made of a rapidly mutating protein core and an extensive c...
International audienceBroadly neutralizing antibodies (bnAbs) directed against the mannose-patch on ...
International audienceBroadly neutralizing antibodies (bnAbs) directed against the mannose-patch on ...
International audienceBroadly neutralizing antibodies (bnAbs) directed against the mannose-patch on ...
<div><p>Understanding the molecular determinants of sensitivity and resistance to neutralizing antib...
Human immunodeficiency virus types 1 and 2 (HIV-1 and HIV-2) are the etiological agents of AIDS in h...
The major target of the neutralizing antibody response to infection by the human immunodeficiency vi...
Background: Broadly neutralizing antibodies (bnAbs) directed against the mannose-patch on the HIV en...
The monoclonal antibody (MAb) 2G12 recognizes a cluster of high-mannose oligosaccharides on the huma...
AbstractThe N-glycan g15 within the HIV-1 gp120 V3 loop efficiently blocks antibodies to facilitate ...
The N-linked oligomannose glycans of HIV gp120 are a target for both microbicide and vaccine design....
The V3 region of the human immunodeficiency virus type 1 envelope protein gp120 constitutes a potent...
AbstractA conserved N-glycan present within the V3 loop of gp120 modulates the sensitivity to neutra...
AbstractA conserved N-glycan present within the V3 loop of gp120 modulates the sensitivity to neutra...
The HIV-1 surface glycoprotein, gp120, is made of a rapidly mutating protein core and an extensive c...
The HIV-1 surface glycoprotein, gp120, is made of a rapidly mutating protein core and an extensive c...
International audienceBroadly neutralizing antibodies (bnAbs) directed against the mannose-patch on ...
International audienceBroadly neutralizing antibodies (bnAbs) directed against the mannose-patch on ...
International audienceBroadly neutralizing antibodies (bnAbs) directed against the mannose-patch on ...
<div><p>Understanding the molecular determinants of sensitivity and resistance to neutralizing antib...
Human immunodeficiency virus types 1 and 2 (HIV-1 and HIV-2) are the etiological agents of AIDS in h...
The major target of the neutralizing antibody response to infection by the human immunodeficiency vi...
Background: Broadly neutralizing antibodies (bnAbs) directed against the mannose-patch on the HIV en...
The monoclonal antibody (MAb) 2G12 recognizes a cluster of high-mannose oligosaccharides on the huma...
AbstractThe N-glycan g15 within the HIV-1 gp120 V3 loop efficiently blocks antibodies to facilitate ...
The N-linked oligomannose glycans of HIV gp120 are a target for both microbicide and vaccine design....